59491-1 |
Collaborative staging site-specific factor 9 |
Prid |
Cancer.XXX |
Pt |
Nom |
|
|
ACTIVE |
Collaborative staging site-specific factor 9 Cancer |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TUMRRGT |
|
59491-1 |
|
|
|
|
|
|
|
|
0 |
CS site-specific factor 9 Cancer |
|
|
|
N |
|
CA; CS; CS site-specific factor 9; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified |
2.34 |
2.34 |
|
|
|
|
|
|
|
|
|
|
|
0 |
59492-9 |
Collaborative staging site-specific factor 10 |
Prid |
Cancer.XXX |
Pt |
Nom |
|
|
ACTIVE |
Collaborative staging site-specific factor 10 Cancer |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TUMRRGT |
|
59492-9 |
|
|
|
|
|
|
|
|
0 |
CS site-specific factor 10 Cancer |
|
|
|
N |
|
CA; CS; CS site-specific factor 10; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified |
2.34 |
2.34 |
|
|
|
|
|
|
|
|
|
|
|
0 |
59493-7 |
Collaborative staging site-specific factor 11 |
Prid |
Cancer.XXX |
Pt |
Nom |
|
|
ACTIVE |
Collaborative staging site-specific factor 11 Cancer |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TUMRRGT |
|
59493-7 |
|
|
|
|
|
|
|
|
0 |
CS site-specific factor 11 Cancer |
|
|
|
N |
|
CA; CS; CS site-specific factor 11; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified |
2.34 |
2.34 |
|
|
|
|
|
|
|
|
|
|
|
0 |
59494-5 |
Collaborative staging site-specific factor 12 |
Prid |
Cancer.XXX |
Pt |
Nom |
|
|
ACTIVE |
Collaborative staging site-specific factor 12 Cancer |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TUMRRGT |
|
59494-5 |
|
|
|
|
|
|
|
|
0 |
CS site-specific factor 12 Cancer |
|
|
|
N |
|
CA; CS; CS site-specific factor 12; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified |
2.34 |
2.34 |
|
|
|
|
|
|
|
|
|
|
|
0 |
59495-2 |
Collaborative staging site-specific factor 13 |
Prid |
Cancer.XXX |
Pt |
Nom |
|
|
ACTIVE |
Collaborative staging site-specific factor 13 Cancer |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TUMRRGT |
|
59495-2 |
|
|
|
|
|
|
|
|
0 |
CS site-specific factor 13 Cancer |
|
|
|
N |
|
CA; CS; CS site-specific factor 13; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified |
2.34 |
2.34 |
|
|
|
|
|
|
|
|
|
|
|
0 |
59496-0 |
Collaborative staging site-specific factor 14 |
Prid |
Cancer.XXX |
Pt |
Nom |
|
|
ACTIVE |
Collaborative staging site-specific factor 14 Cancer |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TUMRRGT |
|
59496-0 |
|
|
|
|
|
|
|
|
0 |
CS site-specific factor 14 Cancer |
|
|
|
N |
|
CA; CS; CS site-specific factor 14; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified |
2.34 |
2.34 |
|
|
|
|
|
|
|
|
|
|
|
0 |
59497-8 |
Collaborative staging site-specific factor 15 |
Prid |
Cancer.XXX |
Pt |
Nom |
|
|
ACTIVE |
Collaborative staging site-specific factor 15 Cancer |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TUMRRGT |
|
59497-8 |
|
|
|
|
|
|
|
|
0 |
CS site-specific factor 15 Cancer |
|
|
|
N |
|
CA; CS; CS site-specific factor 15; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified |
2.34 |
2.34 |
|
|
|
|
|
|
|
|
|
|
|
0 |
59498-6 |
Collaborative staging site-specific factor 16 |
Prid |
Cancer.XXX |
Pt |
Nom |
|
|
ACTIVE |
Collaborative staging site-specific factor 16 Cancer |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TUMRRGT |
|
59498-6 |
|
|
|
|
|
|
|
|
0 |
CS site-specific factor 16 Cancer |
|
|
|
N |
|
CA; CS; CS site-specific factor 16; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified |
2.34 |
2.34 |
|
|
|
|
|
|
|
|
|
|
|
0 |
59499-4 |
Collaborative staging site-specific factor 17 |
Prid |
Cancer.XXX |
Pt |
Nom |
|
|
ACTIVE |
Collaborative staging site-specific factor 17 Cancer |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TUMRRGT |
|
59499-4 |
|
|
|
|
|
|
|
|
0 |
CS site-specific factor 17 Cancer |
|
|
|
N |
|
CA; CS; CS site-specific factor 17; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified |
2.34 |
2.34 |
|
|
|
|
|
|
|
|
|
|
|
0 |
595-9 |
Bacteria |
Prid |
Abscess |
Pt |
Nom |
Aerobic culture |
|
ACTIVE |
Bacteria identified in Abscess by Aerobe culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
595-9 |
|
Aerobic culture |
|
|
Both |
|
|
|
0 |
Bacteria Absc Aerobe Cult |
|
|
|
|
|
Absc; Aerobe; Aerobe Cult; Aerobed; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; UniversalLabOrders |
2.78 |
1 |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; |
218 |
5950-1 |
Coagulation surface induced.factor substitution^20M post incubation after addition of normal plasma |
Time |
PPP |
Pt |
Qn |
Coag |
|
ACTIVE |
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --20M post incubation with normal plasma |
|
MIN |
DefinitionDescription |
|
|
s |
|
|
|
|
|
|
COAG |
|
5950-1 |
|
Coag |
|
|
Observation |
|
|
|
0 |
aPTT 20M NP PPP |
|
|
|
Y |
|
20M NP; 20M p Inc; Activated partial thromboplastin time; After; aPTT; aPTT correction study; Clot; Clottable; Coag; Coagulation assay; Control; Fac; Fact; Hematology; Heme; Little(A)PTT; Mixing studies; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PST; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube |
2.73 |
1.0d |
|
|
|
|
|
|
|
s |
|
|
|
0 |
59500-9 |
Collaborative staging site-specific factor 18 |
Prid |
Cancer.XXX |
Pt |
Nom |
|
|
ACTIVE |
Collaborative staging site-specific factor 18 Cancer |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TUMRRGT |
|
59500-9 |
|
|
|
|
|
|
|
|
0 |
CS site-specific factor 18 Cancer |
|
|
|
N |
|
CA; CS; CS site-specific factor 18; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified |
2.34 |
2.34 |
|
|
|
|
|
|
|
|
|
|
|
0 |
59501-7 |
Collaborative staging site-specific factor 19 |
Prid |
Cancer.XXX |
Pt |
Nom |
|
|
ACTIVE |
Collaborative staging site-specific factor 19 Cancer |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TUMRRGT |
|
59501-7 |
|
|
|
|
|
|
|
|
0 |
CS site-specific factor 19 Cancer |
|
|
|
N |
|
CA; CS; CS site-specific factor 19; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified |
2.34 |
2.34 |
|
|
|
|
|
|
|
|
|
|
|
0 |
59502-5 |
Collaborative staging site-specific factor 20 |
Prid |
Cancer.XXX |
Pt |
Nom |
|
|
ACTIVE |
Collaborative staging site-specific factor 20 Cancer |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TUMRRGT |
|
59502-5 |
|
|
|
|
|
|
|
|
0 |
CS site-specific factor 20 Cancer |
|
|
|
N |
|
CA; CS; CS site-specific factor 20; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified |
2.34 |
2.34 |
|
|
|
|
|
|
|
|
|
|
|
0 |
59503-3 |
Collaborative staging site-specific factor 21 |
Prid |
Cancer.XXX |
Pt |
Nom |
|
|
ACTIVE |
Collaborative staging site-specific factor 21 Cancer |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TUMRRGT |
|
59503-3 |
|
|
|
|
|
|
|
|
0 |
CS site-specific factor 21 Cancer |
|
|
|
N |
|
CA; CS; CS site-specific factor 21; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified |
2.34 |
2.34 |
|
|
|
|
|
|
|
|
|
|
|
0 |
59504-1 |
Collaborative staging site-specific factor 22 |
Prid |
Cancer.XXX |
Pt |
Nom |
|
|
ACTIVE |
Collaborative staging site-specific factor 22 Cancer |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TUMRRGT |
|
59504-1 |
|
|
|
|
|
|
|
|
0 |
CS site-specific factor 22 Cancer |
|
|
|
N |
|
CA; CS; CS site-specific factor 22; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified |
2.34 |
2.34 |
|
|
|
|
|
|
|
|
|
|
|
0 |
59505-8 |
Collaborative staging site-specific factor 23 |
Prid |
Cancer.XXX |
Pt |
Nom |
|
|
ACTIVE |
Collaborative staging site-specific factor 23 Cancer |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TUMRRGT |
|
59505-8 |
|
|
|
|
|
|
|
|
0 |
CS site-specific factor 23 Cancer |
|
|
|
N |
|
CA; CS; CS site-specific factor 23; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified |
2.34 |
2.34 |
|
|
|
|
|
|
|
|
|
|
|
0 |
59506-6 |
Collaborative staging site-specific factor 24 |
Prid |
Cancer.XXX |
Pt |
Nom |
|
|
ACTIVE |
Collaborative staging site-specific factor 24 Cancer |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TUMRRGT |
|
59506-6 |
|
|
|
|
|
|
|
|
0 |
CS site-specific factor 24 Cancer |
|
|
|
N |
|
CA; CS; CS site-specific factor 24; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified |
2.34 |
2.34 |
|
|
|
|
|
|
|
|
|
|
|
0 |
59507-4 |
Collaborative staging site-specific factor 25 |
Prid |
Cancer.XXX |
Pt |
Nom |
|
|
ACTIVE |
Collaborative staging site-specific factor 25 Cancer |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TUMRRGT |
|
59507-4 |
|
|
|
|
|
|
|
|
0 |
CS site-specific factor 25 Cancer |
|
|
|
N |
|
CA; CS; CS site-specific factor 25; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified |
2.34 |
2.34 |
|
|
|
|
|
|
|
|
|
|
|
0 |
59508-2 |
Collaborative staging version.current |
Prid |
Cancer.XXX |
Pt |
Nom |
|
|
ACTIVE |
Collaborative staging version.current Cancer |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TUMRRGT |
|
59508-2 |
|
|
|
|
|
|
|
|
0 |
CS version current Cancer |
|
|
|
N |
|
CA; CS; CS version current; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified |
2.34 |
2.34 |
|
|
|
|
|
|
|
|
|
|
|
0 |
59509-0 |
Date case completed.COC |
Date |
Cancer case.XXX |
Pt |
Qn |
|
|
ACTIVE |
Date case completed.COC Cancer case |
|
MIN |
DefinitionDescription |
|
|
MMDDYY |
|
|
|
|
|
|
TUMRRGT |
|
59509-0 |
|
|
|
|
|
|
|
|
0 |
Date case completed.COC Cancer case |
|
|
|
N |
|
CA; Commission on Cancer; Misc; Miscellaneous; Oncology; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified |
2.5 |
2.34 |
|
|
|
|
|
|
|
|
|
|
|
0 |
5951-9 |
Coagulation surface induced.factor substitution^immediately after addition of normal plasma |
Time |
PPP^Control |
Pt |
Qn |
Tilt tube |
|
DEPRECATED |
Deprecated Activated partial thrombplastin time (aPTT).factor substitution in Platelet poor plasma from control by Coagulation assay --immediately after addition of normal plasma |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
COAG |
|
5951-9 |
|
Tilt tube |
|
|
|
|
|
|
0 |
Deprecated aPTT imm NP PPP Cont Qn |
|
|
|
|
|
Activated partial thromboplastin time; aPTT; aPTT correction study; Coag; Contrl; Control; Fac; Fact; Hematology; Heme; imm NP; Immediatedly after 1:1 addition of; Little(A)PTT; Mixing studies; Normal; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PTT; QNT; Quan; Quant; Quantitative; Random; Surf |
2.36 |
1.0d |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
59510-8 |
Date case initiated |
Date |
Cancer case.XXX |
Pt |
Qn |
|
|
ACTIVE |
Date case initiated Cancer case |
|
MIN |
DefinitionDescription |
|
|
MMDDYY |
|
|
|
|
|
|
TUMRRGT |
|
59510-8 |
|
|
|
|
|
|
|
|
0 |
Date case initiated Cancer case |
|
|
|
N |
|
CA; Misc; Miscellaneous; Oncology; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified |
2.5 |
2.34 |
|
|
|
|
|
|
|
|
|
|
|
0 |
59511-6 |
Flag for Date of conclusive diagnosis not populated |
Prid |
Cancer.XXX |
Pt |
Nom |
|
|
ACTIVE |
Flag for Date of conclusive diagnosis not populated Cancer |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TUMRRGT |
|
59511-6 |
|
|
|
|
|
|
|
|
0 |
Flag for Date of conclusive Dx Cancer |
|
|
|
N |
|
CA; Date of conclusive Dx; Dx; Flag for Date of conclusive Dx; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified |
2.34 |
2.34 |
|
|
|
|
|
|
|
|
|
|
|
0 |
59512-4 |
Flag for Hospital admission.first contact not populated |
Prid |
Cancer.XXX |
Pt |
Nom |
|
|
ACTIVE |
Flag for Hospital admission.first contact not populated Cancer |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TUMRRGT |
|
59512-4 |
|
|
|
|
|
|
|
|
0 |
Flag for 1st contact Cancer |
|
|
|
N |
|
CA; Flag for 1st contact; Hosp; Hosp adm 1st contact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified |
2.34 |
2.34 |
|
|
|
|
|
|
|
|
|
|
|
0 |